Synthetic biology design is ultimately constrained by our capacity to specify function of synthetic parts at the DNA sequence level. This capacity would redirect the field away from relying on a "parts-off-the-shelf" strategy and toward an approach marked by pure, synthetic design and customizable specification. Toward this end, great strides have been made to enable model-based design of cellular behavior^[@R1]^ and to allow for rational design of small sequences (such as ribosome binding sites, transcription factors and enhancers)^[@R2]-[@R8]^. Yet, pure *de novo* design of full promoters, one of the most fundamental components in synthetic circuits, remains difficult, especially in eukaryotic model organisms like yeast. Traditional approaches spanning the last decade of promoter engineering efforts^[@R8]^ rely upon part-mining^[@R9]^, mutagenesis strategies^[@R10]-[@R12]^, and/or chimeric design^[@R6],\ [@R7]^ to identify promoter variants. More recently, data-driven rules have been developed to describe promoters as a first step toward comprehensive models^[@R13]^.

In contrast, here we present the first approach for DNA-level specification of promoter activity based on predicted nucleosome affinity. Previous studies have demonstrated both the importance of chromatin structure in promoter strength^[@R14]^ as well as the capacity to alter transcription rates by modifying nucleosome binding sequences^[@R13]^. Following these studies, our overall hypothesis is that promoter activity can be predicted and controlled based on nucleosome architecture ([Figure 1](#F1){ref-type="fig"}). To test this hypothesis, we made use of a previously-developed hidden Markov model to *de novo* predict nucleosome occupancy along an arbitrary DNA sequence^[@R15]^. This hidden Markov model has been validated in another paper^[@R15]^ and was found to be predictive of nucleosome position. By coupling this developed model along with our hypothesis, our approach can enable both the redesign of endogenous promoter sequences as well as the *de novo* design of synthetic promoters in a single design cycle.

Results {#S1}
=======

Rational redesign of native yeast promoters {#S2}
-------------------------------------------

Our earliest efforts in yeast promoter engineering^[@R10],\ [@R11]^ relied upon large-scale mutagenesis and selection to generate a *TEF1* promoter library. This process clearly demonstrated that distributed point mutations in promoters can alter expression levels---although in most cases, lower expression than wild-type is obtained. Here, we sought to extract a design principle from this 15-member promoter library that collectively spans a 15-fold dynamic range in expression and encompasses between 5 and 71 mutations across 401 base-pairs. By evaluating predicted nucleosome affinity across the 15-member *TEF1* promoter library, we found that the cumulative sum of predicted nucleosome affinity across the entire promoter (hereafter referred to as the "cumulative affinity score") is inversely proportional to promoter strength in a very robust, predictable manner, despite the great diversity of sequence and transcription factor binding site mutations ([Figure 2A-B](#F2){ref-type="fig"}). This strong correlation underpins the potential for nucleosome architecture to be used generically as a design principle for promoter engineering in yeast.

Using these results along with a computational exploration of sequence space, we established a framework to specify increased promoter strength at the DNA level by designing sequences with decreased predicted nucleosome affinity. Although this study focused on predictive increases in promoter activity, this approach may also be used to more generally decrease or otherwise tune promoter strength. Our nucleosome affinity minimization technique employed a greedy algorithm to minimize the cumulative affinity score over several rounds of optimization; in each round, all possible candidates differing by a single base pair were computationally generated and the candidate with the smallest cumulative affinity score was used as an input for the next round. Importantly, this optimization was bounded by the sequence-based requirement to avoid the destruction or creation of well-known transcription factor binding sites^[@R16],\ [@R17]^ (**Supplementary Software**). A greedy algorithm was chosen for computational convenience rather than for exhaustive nucleosome occupancy optimization. Moreover, we have validated this choice by finding that optimizing over all pairs of nucleotide substitutions in each round resulted in promoters with only slightly lower predicted nucleosome affinity although at a substantially increased computational cost (700 sec per mutation vs. 218,000 sec per pair of mutations in the case of *CYC1*) ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). Thus, the greedy algorithm is well-suited for the rapid identification of designer promoter sequences. Since each round of the greedy algorithm evaluated all candidates differing by single base pair changes (a space on the order of 10^3^ for each promoter tested), and because our design cycle consisted of 50-100 rounds, this proof-of-concept demonstration corresponds to sequence space searches of upwards of 10^5^ in a facile manner. It should be emphasized that the searched space is small compared to the total available sequence space for a promoter of this length (10^156^). The greedy algorithm chosen in this work is one way in which to computationally parse this large sequence landscape. The scope of this sequence space for the first round of the *CYC1* promoter optimization is depicted in [Figure 3](#F3){ref-type="fig"}. This initial search illustrates hot-spots in sequence space that result in lower cumulative nucleosome affinity scores. For example, in [Figure 3A](#F3){ref-type="fig"}, there are a series of variants clustered near the -100 base-pair position that show decreased cumulative nucleosome affinity scores when mutated to T, and higher scores when mutated to G or C. Furthermore, it should be noted there are examples where changing a particular nucleotide to an A or T does not result in the lowest predicted score for that position even though AT-rich regions are generally less likely to bind nucleosomes.

Using this approach, we successfully defined promoter sequences that experimentally increased the strength of four different native yeast promoters (*CYC1*, *HIS5*, *HXT7*, and *TEF1*) that natively span an order of magnitude in expression level ([Figure 4A](#F4){ref-type="fig"}, [Supplementary Figures 2-7](#SD1){ref-type="supplementary-material"} compare wild-type promoter strengths and predicted nucleosome affinity profiles). In each of these cases, we used our approach to computationally redesign sequences for higher strength promoter variants by choosing the products of select rounds of optimization to synthesize, and then experimentally demonstrating improved transcriptional activity in a plasmid-based system. Furthermore, using the *CYC1* promoter as a test case, we showed that a variety of expression levels can be generated by synthesizing the products of varying rounds of optimization, with *CYC1v1* the product of an early round and *CYC1v3* the product of a late round [Supplementary Table 1](#SD1){ref-type="supplementary-material"} contains full promoter sequences). The greatest improvement in strength over wild-type for all of the redesigned promoters was 3.2-fold, exhibited by the *CYC1v3* promoter, which is the result of the 30^th^ round of optimization. Subsequent measurement of transcript level using quantitative PCR confirmed that the redesigned promoters increased transcriptional expression over each corresponding wild-type promoter ([Figure 4B](#F4){ref-type="fig"}).

It should be noted that nucleosome architecture did not appear to be as limiting among the absolute strongest native promoters in yeast (including *TDH3* and *GAL1*). While our previous work has demonstrated that these promoters have the capacity for increased expression through the use of chimeric hybrid promoters^[@R7]^, no increase in expression was seen in this work ([Supplementary Figure 8](#SD1){ref-type="supplementary-material"}), indicating that nucleosome architecture is likely evolutionarily optimized for these promoters. These two promoters represented the only cases in which false positives were identified by this algorithm. However, a nucleosome architecture approach could still likely be used to tune down the expression of these highest promoters.

To confirm the biological underpinning of this design algorithm, nucleosome occupancy was measured via micrococcal nuclease digestion and quantitative PCR tiling array. This experiment demonstrated that nucleosome occupancy was reduced in *CYC1v3* relative to wild-type *CYC1*, as predicted by the model ([Figure 5](#F5){ref-type="fig"}). These results clearly demonstrate that actual nucleosome occupancy was reduced in the redesigned promoter ([Figure 5A](#F5){ref-type="fig"}). These results can be compared qualitatively to the computational predictions generated by the hidden Markov model, and complement previous work validating the predictive ability of the hidden Markov model^[@R15]^ ([Figures 5B, 5C](#F5){ref-type="fig"}). Collectively, these results confirmed our hypothesis that promoter strength may be controlled by manipulating nucleosome occupancy and demonstrated that nucleosome architecture can be used to specify sequence-function relationships for yeast promoters.

Redesigned promoters function in multiple genetic contexts {#S3}
----------------------------------------------------------

All of the above-described characterization was performed within a singular genetic context, namely a single plasmid design. Thus, we next sought to test the capacity for rationally designed promoters to function in alternative genetic contexts. Specifically, alternative contexts can be used to test the ability of the predicted changes to potentiate nucleosome architecture rearrangements independent of upstream and downstream DNA segments. Differences in the genetic contexts that surround the promoter, either due to the promoter\'s location in the genome or due to the particular gene being expressed, could result in changes to the local chromosomal architecture and could therefore influence the final expression level of the promoter. This phenomenon of genetic loci-dependent expression is well-documented for the yeast genome^[@R18]^.

First, the *CYC1* series of redesigned promoters was evaluated with an alternative reporter gene. In this case, the *yECitrine* gene used in our previous experiments was replaced with a beta-galactosidase gene from *E. coli* (*LacZ*). Beta-galactosidase activity was detected and the relative increase in expression level using this reporter was similar to that from the *yECitrine* constructs ([Figure 6A](#F6){ref-type="fig"}). In this case, *CYC1v3* had a 3.8 fold higher relative expression compared to wild-type *CYC1*.

Second, the *CYC1* series of redesigned promoters was evaluated in a genomic context. In this case, the *K. lactis URA3* gene was cloned upstream of each *CYC1* promoter variant as a marker gene, and the entire cassette was integrated into the *TRP1* locus in the genome of *S. cerevisiae* BY4741. Expression of *yECitrine* was measured using flow cytometry ([Figure 6B](#F6){ref-type="fig"}). The trend and rank order of increased expression level along this series was the same as for the plasmids (both for *yECitrine* and *LacZ*). However, the relative fold-change in expression level was significantly higher for the integrated constructs than for the plasmids, with the highest increase from wild-type being 16-fold for *CYC1v3*. To determine whether this difference was due to the move from the plasmid to the genome or due to the presence of the *URA3* marker gene integrated upstream of the promoter, a set of plasmids containing the *URA3* marker gene were also assayed for *yECitrine* expression ([Figure 6C](#F6){ref-type="fig"}). Interestingly, the fold-change in expression level for these constructs was intermediate between the original plasmid constructs and the integrated constructs, with the highest increase being 5.9-fold for *CYC1v3*. It is therefore likely that both the addition of the marker gene and the integration of the cassette resulted in local repositioning of nucelosomes that changed the final ultimate nucleosome architecture of the expression cassette. Regardless, the redesigned promoters consistently increased expression level and maintained the same rank order, indicating that these rational changes are able to potentiate a decrease in the nucleosome occupancy of yeast promoters in a variety of genetic contexts, thereby increasing expression level in a general manner.

Design and creation of synthetic yeast promoters {#S4}
------------------------------------------------

As a second proof-of-concept, we sought to demonstrate that a model-guided approach can be used to create *de novo* promoters for synthetic biology without requiring the use of a native promoter as a scaffold. Previous attempts to create synthetic *S. cerevisiae* promoters usually relied upon hybrids of multiple promoter parts^[@R7]^, synthetic zinc finger transcription factor binding sites inserted into a scaffold of a native promoter^[@R4],\ [@R5]^, the use of synthetic TALE transcription factors^[@R19]^, or random libraries and screening^[@R20]^. A purely synthetic, *de novo* designed promoter created merely upon the arrangement of desired transcription factors has not been previously demonstrated. Specifically, our goal in this proof-of-concept was to demonstrate that, even without explicit information related to promoter architecture rules, it is possible to computationally specify active promoter sequences. To use our design and search strategy to create such a synthetic promoter, we specified two arrangements as initial lead scaffolds for the promoter design. Specifically, we utilized common glycolytic transcription factor binding sites embedded in random spacer sequences as the lead designs for our algorithm ([Figure 7A](#F7){ref-type="fig"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"} compares scaffolds to native promoters). This approach resulted in two synthetic base scaffolds: *Psynth1*, and a shorter version *Psynth2*, which were both used as inputs to our nucleosome affinity minimization technique. Three synthetic promoters were designed for *Psynth1* and *Psynth2*: one version from the sixth round of optimization, a second version from the 50^th^ or 30^th^ round, and a third version from the 98^th^ or 59^th^ round, respectively. As a result, a total search space of 10^5^ was evaluated over the entire design cycle for each base scaffold. The result was six DNA-specified promoters that were subsequently characterized. All six designs were found to be active promoters *in vivo* ([Figure 7B](#F7){ref-type="fig"}) that span nearly a 20-fold dynamic range with most of them being similar or higher in strength to the *CYC1* promoter---a promoter representative of the mean expression level of native yeast promoters^[@R21]^. The power of our affinity minimization technique to increase promoter activity is especially evident in the case of *Psynth1*. *Psynth1v1* is only marginally higher in expression than the negative control, whereas *Psynth1v2* is 3.5-fold higher and approaches the strength of *CYC1*. *Psynth1v3* is nearly 20-fold higher than *Psynth1v1* and is on par with the strength of a commonly used promoter, the *HXT7* promoter. Moreover, the substantial transcriptional capacity of this purely synthetic promoter places it in the 6^th^ percentile of expression when compared to endogenous yeast promoters^[@R21]^. Furthermore, it should be noted that each of these synthetic promoters is quite distinct on a sequence level from native *S. cerevisiae* promoters. In fact, the most significant homology consisted of a 39 base-pair sequence surrounding the TATA box of *Psynth1* (E-value =0.48). Thus, our *Psynth* promoters are not enriched with native sequences and are therefore pure, *de novo* synthetic designs. Moreover, these *de novo* designed promoters did not require native spacing between transcription factors nor did they require the need to exactly mimic any given native promoter sequence as a scaffold.

Discussion {#S5}
==========

Taken together, these results present the first DNA-level specification of promoter strength for yeast promoters based on a nucleosome architecture model. We have demonstrated the potential of this approach for (1) the redesign of endogenous promoter scaffolds and (2) the design of *de novo* synthetic promoters.

Specifically, native yeast promoters were redesigned into highly homologous sequences with promoter strengths up to 16-fold higher than their wild-type sequences. For each of the four promoter case studies, we improved activity by first interrogating \~10^5^ promoter variants *in silico* (10^3^ candidates were queried per round when searching over all possible single base pair changes, and 10^6^ could be queried per round when searching over doubles, see [Figure 3](#F3){ref-type="fig"}) then characterizing the products of selected rounds of the greedy algorithm *in vivo*. For the case of the *CYC1* promoter, we chose the products of three different rounds of optimization to synthesize. This approach stands in stark contrast to the generation of large mutagenic libraries followed by screening. The extent of expression level increase did not always correlate with the absolute number of base pairs changed, as increases obtained in *TEF1v1* required only five rounds of optimization ([Supplementary Table 1](#SD1){ref-type="supplementary-material"} contains full sequences). However, the utility of the greedy algorithm to sequentially identify increasingly optimal sequences was upheld for each case tested. Nevertheless, a more comprehensive, computational search of this sequence space may be used in place of the greedy algorithm to parse this complex landscape. Regardless, each of the redesigned promoters required multiple rounds (i.e. basepair changes) to significantly increase expression, underscoring that these specific high-strength-potentiating combinations would be undetectable in random mutant libraries. Additionally, we confirmed that these improvements were indeed due to decreased nucleosome occupancy in the case of the *CYC1v3* promoter. Finally, we showed that these rationally designed promoters consistently display increased expression in a variety of genetic contexts, demonstrating that these directed changes are able to potentiate a decrease in nucleosome occupancy despite variation in the surrounding chromosomal architecture.

Further, we created several fully synthetic yeast promoters which attain a variety of strengths and have minimal homology to any native sequence. The base promoter scaffolds for these synthetic promoters were only very loosely based on the native glycolytic promoters in yeast, demonstrating that close homology to native promoters may not be necessary for synthetic eukaryotic promoters. Given this surprising result, the range of synthetic promoter design possibilities is unbounded by traditional promoter architecture design rules inferred from native promoter structures. Furthermore, one of our synthetic promoters, *Psynth1v3*, is on par with a commonly used promoter for metabolic engineering purposes, the *HXT7* promoter, and resides among the top six percent of native yeast promoters in regards to strength^[@R21]^.

This work confirms that nucleosome occupancy is an important, causative factor limiting the strength of native yeast promoters and is likely an evolutionary mechanism for controlling transcriptional strength^[@R22]^. This method significantly advances the state-of-the-art in a field currently entrained in mutation and chimeric library construction by enabling the predictable specification of synthetic parts in single design-build-test cycles rather than by the generation of large libraries. Thus, this method opens the door to the rational design and creation of synthetic eukaryotic promoters as well as expands our capacity for pure synthetic biology design.

Methods {#S6}
=======

Computational methods {#S7}
---------------------

Nucleosome occupancy of native yeast promoters was optimized through the use of a computational algorithm. First, transcription factor binding sites present in the wild-type sequence were manually identified through the use of the Yeast Promoter Atlas^[@R16]^. Then, nucleotides outside these sites were systematically perturbed using a custom MATLAB script, which utilized a FORTRAN implementation of the Nucleosome Positioning Prediction (NuPoP) engine^[@R15]^ to predict nucleosome affinity. Minor modifications to NuPoP were made to enable the acceptance of command-line inputs. The cumulative sum of nucleosome affinities over each candidate was then computed and the nucleotide substitution resulting in the largest decrease in total nucleosome affinity was saved as the product of one round of optimization. This sequence was then systematically perturbed as above so that successive increases in promoter strength were achieved in an iterative fashion. This MATLAB script additionally avoided the creation of new transcription factor binding sites^[@R17]^ and also restricted promoter designs to those which could be synthesized as gBlocks by Integrated DNA Technologies, Inc. (Coralville, Iowa) which was the vendor chosen to provide the synthetic DNA in this project.

The identity and placement of transcription factor binding sites in the synthetic promoter scaffolds were determined using a bioinformatics analysis of glycolytic promoters as a guide. The occurrence and relative positions of common transcription factor binding sites were catalogued and the average spacing values were calculated ([Supplementary Table 2](#SD1){ref-type="supplementary-material"}). In addition to a consensus TATA box, four transcription factor binding sites were included in the upstream activating sequence area of the synthetic promoter: a Reb1p binding site, a Rap1p binding site, and two Gcr1p binding sites. Consensus binding site sequences were used^[@R17]^. *Psynth1* was designed using the average lengths between binding sites and *Psynth2* was identical, except that the minimum length of the two longest regions (between the GCR1p binding site and the TATA box and between the TATA box and the transcription start site) was used instead of the average length in an attempt to make a shorter promoter. The *TDH3* transcription start site and 5' UTR was used for both synthetic promoters in order to prevent any confounding issues from having different 5' UTR structures between promoters. Once the binding sites and relative positions were chosen, this information was then used as input to a custom MATLAB script to generate the *Psynth* series of vectors. First, the undetermined nucleotides between each transcription factor binding site were randomly seeded at a GC content of 35%. Once any inadvertent transcription factor binding sites generated in these regions were removed, nucleosome affinity was reduced in an iterative fashion as above. As before, the creation of new transcription factor binding sites or sequences which could not be synthesized was avoided. All computations were performed on an Intel Core 2 Duo processor running Windows 7.

Strains and media {#S8}
-----------------

*Saccharomyces cerevisiae* strains BY4741 (*MAT a; his3*Δ*1; leu2*Δ*0; met15*Δ*0; ura3*Δ*0*) and BY4741 Δ*P~CYC1~* (*MAT a; his3*Δ*1; leu2*Δ*0; met15*Δ*0; ura3*Δ*0; P~CYC1~::ura3*) were used in this study. BY4741 Δ*P~CYC1~* was generated using the "delete and repeat" knockout method^[@R23]^ with the *K. lactis URA3* gene from plasmid PUG72 as the selectable marker. Primers for the generation of the knockout cassette are in [Supplementary Table 3](#SD1){ref-type="supplementary-material"}. Integration of the *CYC1* promoter variants and *yECitrine* cassettes was completed by cloning the *K. lactis URA3* gene upstream of each *CYC1* promoter variant cassette (see below for plasmid construction) and then using the "delete and repeat" method to integrate both genes into the *TRP1* locus. See [Supplementary Table 3](#SD1){ref-type="supplementary-material"} for primers. Yeast strains were propagated at 30°C in yeast complete synthetic medium (CSM). CSM is composed of 6.7 g L^−1^ yeast nitrogen base, 20 g L^−1^ glucose and either CSMHIS or CSM-URA supplement (MP Biomedicals, Solon, OH), depending on the required auxotrophic selection. *Escherichia coli* strain *DH10B* was used for all cloning and plasmid propagation. *DH10B* was grown at 37°C in Luria-Bertani (LB) media supplemented with 50 μg/mL of ampicillin. All strains were cultivated with 225 RPM orbital shaking. Yeast and bacterial strains were stored at −80°C in 15% glycerol.

Plasmid construction {#S9}
--------------------

All plasmids used in this study were based on the p413 yeast shuttle vectors^[@R24]^. These plasmids contain the *HIS3* gene as the auxotrophic marker. The *TEF1* and *CYC1* promoters were available in the parent plasmid set. The *TEF1 mutant* series of promoters and the *yECitrine* and *LacZ* genes were cloned via PCR from plasmids^[@R10],\ [@R11],\ [@R23],\ [@R25]^. The *HXT7* and *HIS5* promoters were cloned via PCR from extracted BY4741 gDNA obtained using the Wizard Genomic DNA Extraction Kit from Promega (Madison, WI). Redesigned and synthetic promoters were ordered as gBlock fragments from Integrated DNA Technologies, Inc. (Coralville, IA) and then cloned via PCR ([Supplementary Table 1](#SD1){ref-type="supplementary-material"} for promoter sequences and [Supplementary Table 3](#SD1){ref-type="supplementary-material"} for all primer sequences). Standard cloning and bacterial transformations were performed according to Sambrook and Russell^[@R26]^. PCR reactions used Phusion High-Fidelity DNA Polymerase from New England Biolabs (Ipswich, MA) and followed supplier instructions; primers were purchased from Integrated DNA Technologies. Antarctic phosphatase and all restriction enzymes were purchased from New England Biolabs. Fermentas T4 DNA ligase and all other enzymes and chemicals were purchased through Thermo Fisher Scientific (Waltham, MA). Vectors were isolated using the Zyppy Plasmid Miniprep kit from Zymo Research Corp. (Irvine, CA) and DNA purification was performed with a Qiaquick PCR Cleanup kit (Qiagen, Valencia, CA). Plasmids were transformed using the EZ Yeast Transformation II Kit from Zymo Research Corp. according to manufacturer\'s instructions.

Flow cytometry {#S10}
--------------

Fluorescence from strains expressing the *yECitrine* gene was measured using a FACS Fortessa (BD Biosciences) in biological triplicate. Cells were grown for 16 hours to mid-log phase from a starting OD~600~=0.005. For each strain, 10,000 events were collected using a YFP fluorochrome with a voltage of 355. Day to day voltage variability was mitigated by measuring all comparable strains on the same day. FlowJo (Tree Star Inc., Ashland, OR) was used to analyze data. For plasmids expressing *yECitrine*, positive YFP expression (as compared to strains expressing a control plasmid with no *yECitrine*) was gated, and mean fluorescence values were calculated across the biological triplicates. For genome-integrated expression of *yECitrine* near auto-fluorescence values, mean fluorescence was calculated first, then the mean autofluorescence value (as measured from strains not expressing *yECitrine*) was subtracted.

Beta-galactosidase assay {#S11}
------------------------

Strains expressing the *LacZ* gene were evaluated for beta-galactosidase activity through the chemiluminescent Gal-Screen system (Applied Biosystems). Yeast cultures were grown for 16 hours to mid-log phase from a starting OD~600~=0.005. Prior to the assay, cultures were diluted with fresh media to approximately OD~600~=0.01 to 0.07. OD~600~ was measured, and then cultures were treated with Gal-Screen Reaction Buffer according to the manufacturer\'s instructions. Luminescence was quantified using a Mithras LB 940 luminometer (Berthold Technologies). Day to day variation was avoided by measuring all samples on the same day. The average luminescence across biological replicates was calculated.

Quantitative PCR {#S12}
----------------

To measure mRNA levels resulting from redesigned promoters, quantitative PCR was performed. Yeast cultures were grown for 16 hours to mid-log phase from a starting OD~600~=0.005, and RNA was extracted using Zymolyase digestion of the yeast cell wall followed by the Quick-RNA MiniPrep kit according to manufacturer\'s instructions (Zymo Research Corp.). cDNA was generated from the purified RNA via the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Primers for qPCR were designed using the PrimerQuest® tool and obtained from Integrated DNA Technologies ([Supplementary Table 3](#SD1){ref-type="supplementary-material"} for primers). Quantitative PCR was performed on a ViiA7 qPCR system (Life Technologies) using SYBR Green Master Mix from Roche (Penzberg, Germany), following the manufacturer\'s instructions with an annealing temperature of 58°C and 0.25 μL of cDNA product per 20 μL reaction. The *ALG9* gene was used as a housekeeping gene, and the relative *yECitrine* transcript level was obtained by calculating the average values between three technical replicates for each sample.

Nucleosome mapping {#S13}
------------------

Nucleosome position and density was mapped in the *CYC1* and *CYC1v3* promoters. The BY4741 Δ*P~CYC1~* strain was used for this part of the study in order to prevent contaminating genomic sequence from confounding the results. Plasmids p413-*CYC1*-*yECitrine* and p413-*CYC1v3*-*yECitrine* were independently transformed into the strain as described above. Mononucleosome sized genomic DNA fragments were then isolated from each strain^[@R27]^. To conduct these measurements, 200 mL of culture was grown to approximately OD~600~=0.8. Cells were treated with 1% formaldehyde for 30 minutes at 30°C. The reaction was stopped by adding glycine to a final concentration of 125mM and cells were centrifuged at 3000g and washed twice in 20 mL of PBS. Cells were then resuspended in in 20 mL Zymolyase buffer (1 M sorbitol, 50 mM Tris pH 7.4, 10 mM 2-mercaptoethanol), then spheroplasted with 50 U Zymolyase (Zymo Research Corp.) for 40 min at 30°C. Cells were then washed once with 10 mL Zymolyase buffer and resuspended in 2 mL NP Buffer (1 M sorbitol, 50 mM NaCl, 10 mM Tris pH 7.4, 5 mM MgCl~2~, 0.075% NP 40, 1 mM 2-mercaptoethanol, 500 μM spermidine). Aliquots of 500 μL were split between four tubes for each sample, and CaCl~2~ was added to a final concentration of 3 mM. Micrococcal nuclease (New England Biolabs) digestions were performed at concentrations ranging from 100 to 600 U/mL for 10 min at 37°C. Reactions were stopped by adding 100 μL stop buffer (5% SDS, 500 mM EDTA). Proteinase K (New England Biolabs) was added to each tube at a final concentration of 100 mg/mL and incubated at 65°C for approximately 8 hours. DNA was purified using phenol-chloroform-isoamyl alcohol (25:24:1) extraction and ethanol precipitation. Resuspended DNA was treated with DNase-free RNase (Promega) for 30 min at 37°C, then re-extracted using phenol-chloroform-isoamyl alcohol and ethanol precipitation. DNA was resuspended in 50 μL water and run in a 2% agarose gel. The dilution with the most apparent mono-nucleosome sized band (approximately 150 bp) was extracted using the Invitrogen Pure-Link gel extraction kit (Life Technologies, Carlsbad, CA).

A tiling array of primer sets was designed for each promoter^[@R14]^ to perform quantitative PCR. To accomplish this, primers were designed using the PrimerQuest® tool and obtained from Integrated DNA Technologies ([Supplementary Table 4](#SD1){ref-type="supplementary-material"} for primers) and were placed approximately 50-100 basepairs apart. Quantitative PCR was performed as described above using 0.5 μL of mono-nucleosome DNA extract (at 10 ng/μL) per 10 μL reaction. A section of the ampicillin gene on each plasmid was used as a control to account for any variation in total plasmid copy number between the two samples. Standard curves were created for each primer set using a serial dilution of the corresponding whole plasmid with concentration varying from 5×10^7^ to 5×10^3^ copies per μL. The relative copy number for each primer set in the promoter was calculated using these standard curves and comparing to the ampicillin primer set.
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![*A model for promoter strength.* Native promoters can be redesigned for increased strength by decreasing nucleosome affinity. Transcription factors are designated "TF" and binding sites are "TFBS."](nihms-591067-f0001){#F1}

![Nucleosome affinity correlates to mutant promoter strength. **A)** Computational nucleosome affinity profiles generated using a hidden Markov model^[@R15]^ for several *TEF1* mutant promoters^[@R10],\ [@R11]^, with *TEF1 mutant 2* being the weakest and *TEF1 mutant 6* the strongest **B)** Experimental promoter strength as a function of cumulative affinity scores based on profiles in (**A**) for the *TEF1* mutant promoter library.](nihms-591067-f0002){#F2}

![Computational candidates generated for one round of the CYC1 promoter redesign. Each candidate queried for the *CYC1* promoter redesign was plotted for the first round of **A)** a greedy algorithm searching over all possible single base pair changes per round and **B)** a greedy algorithm searching over all possible double base pair changes per round. For the algorithm searching over all single base pair changes, known transcription factor binding sites, TATA boxes, and transcription start sites are annotated. For the algorithm searching over all pairs, each point on the surface represents the most favorable pair of mutations (out of 16 possibilities) for a particular pair of positions.](nihms-591067-f0003){#F3}

![Redesign of native yeast promoters for increased expression by decreasing nucleosome affinity. **A)** Computationally redesigned promoters exhibiting upwards of 3.2-fold increases in fluorescence over wild-type. Error bars represent standard deviation from three biological replicates. See [Supplementary Figures 2-7](#SD1){ref-type="supplementary-material"} for a comparison of wild-type promoter strengths and predicted nucleosome affinity profiles. **B)** Relative transcript level as measured by quantitative PCR for the promoters shown in (**A**). Error bars represent standard deviation from three technical replicates.](nihms-591067-f0004){#F4}

![Nucleosome occupancy is decreased in the CYC1v3 promoter relative to the CYC1 promoter. **A)** Relative abundance of nucleosomal DNA as measured by micrococcal nuclease assays in *CYC1* and *CYC1v3* promoters. After micrococal nuclease digestion, copy number was measured across the promoter using a quantitative PCR (qPCR) tiling array. Each point represents the relative copy number of the qPCR amplicon centered at that base-pair location. Relative copy number of each amplicon was calculated in comparison to a control amplicon in the ampicillin gene. Error bars represent standard deviation from three technical measurements of each amplicon and ampicillin gene. The redesigned *CYC1v3* promoter exhibits lower nucleosome occupancy in the promoter region than the wild-type version. **B)** Predicted nucleosome affinity profile for the *CYC1* and *CYC1v3* promoters using the hidden Markov model^[@R15]^. **C)** Predicted nucleosome occupancy profiles for the *CYC1* and *CYC1v3* promoters using the hidden Markov model^[@R15]^.](nihms-591067-f0005){#F5}

![CYC1 promoter redesigns have consistently increased expression levels in different genetic contexts. **A)** Relative expression level from the *CYC1* promoter variants expressing the beta-galactosidase gene *LacZ* as measured by a chemiluminescent assay. Background luminescence from a strain not expressing *LacZ* was negligible. **B)** Relative expression level from the *CYC1* promoter variants expressing *yECitrine* and integrated into the *TRP1* locus of the BY4741 genome. **C)** Relative expression level from the *CYC1* promoter variants expressing *yECitrine* with the *K. lactis URA3* gene integrated upstream of the promoter. These plasmid constructs were the basis for the integration cassette used to create the strains measured in (**B**). Error bars represent standard deviation from biological triplicate.](nihms-591067-f0006){#F6}

![Model-guided creation of de novo synthetic promoters. **A)** Two synthetic lead sequences, each containing prescribed transcription factor binding sites and randomized linker sequences, were used for *de novo* promoter design. **B)** Three computationally derived versions of each synthetic promoter were tested, one from an early round of optimization, one from an intermediate round, and one from a late round. *Psynth1v1* and *Psynth1v2* are the result of the sixth round, *Psynth1v2* is from the 50th, *Psynth1v3* is from the 98^th^, *Psynth2v2* is from the 30^th^, and *Psynth2v3* is from the 59^th^. Expression levels of the redesigned synthetic promoters spanned a nearly 20-fold range and all were functional. Error bars represent standard deviation of three biological replicates.](nihms-591067-f0007){#F7}
